Duke Radiology Grand Rounds Lectures are conducted on Thursdays at 7:30 a.m.- 8:30 a.m. in Room 2002 Duke North. The mission for Radiology Grand Rounds is to provide an educational format which has a broad appeal to faculty and trainees. If you have any further questions regarding Radiology Grand Rounds, please contact Debbie Griffin at 919-684-7228.
LI-RADS: Past, Present, and Future
LI-RADS is a system for standardized imaging of the liver in patients with HCC. The recent update in 2017 addresses imaging technique, terminology, interpretation, and reporting using US, contrast-enhanced ultrasound, CT, and MRI for surveillance, diagnosis, staging, and treatment response assessment. This lecture briefly reviews the history of LI-RADS and discusses LI-RADS present (focusing on CT and MRI) as well as changes introduced in version 2017. It concludes with a glimpse into LI-RADS future directions.
How We Do Science at Duke
Research is an integral part of academic medicine. It has been particularly prominent in radiology, motivated by its strong technological backbone, its rapid progress, and the expected scientific expertise of its practitioners, creating a need and expectation for continued investment in the science of radiology. Informed by diverse expertise across clinical and basic strengths of the department (with additional participation of Rendon Nelson, Jay Baker, Joseph Lo, and Donald Frush), this Grand Rounds aims to delineate the features of excellence in the practice of science in radiology. Topics covered include the not-so-commonly-disclosed insights and effective models of inquiry and collaboration. We discuss how we move from a possible idea to a project concept, specific aims, study design, resource identification (technical, clinical, statistical), experiments, interpretations of the data, grants, papers, etc, with the objective of encouraging a higher degree of consciousness and intentionality in the process.
Showing the Value of Imaging: What Do New Payment Programs Mean for Radiology?
Medicare, Medicaid, and private insurers are all trying new ways to pay for health care, with the goal of tying payments to better quality and value. New laws have changed the formula Medicare uses to pay physicians, and private insurers are similarly rolling out new bundled payments, accountable care organizations, and other approaches. While these new payment models are intended to remove barriers to delivering high quality, coordinated care, the pace of change is intense. The goal of this talk is to review the current state of value-based payment programs (including the many acronyms thrown around, like MACRA, MIPS, APMs, ACPs, and VBP), what the future holds, how these models affect radiologists, and how radiologists can succeed under them.
Morbidity & Mortality
Department of Radiology Morbidity & Mortality, moderated by Don Frush, M.D., FACR, FAAP
Future for Machine Learning Applied to Thyroid Nodules and ACR TI-RADS
This talk will discuss ongoing research within the Duke Department of Radiology regarding machine learning and thyroid nodules. Topics will include an exploration of current challenges with thyroid nodule imaging and what makes thyroid nodules an appealing target for machine learning, how machine learning might improve thyroid imaging and thyroid ultrasound reporting, and what technical challenges our team faces as we work towards our goal of improving both diagnosis and report consistency
Overview of the Faculty Mentoring Programs within the School of Medicine
This presentation will provide an overview of services that are offered to Duke Faculty, through the Office for Faculty Mentoring. These offerings compliment the outstanding programs that are offered through the Office for Faculty, under the leadership of Dean Ann Brown. The Office for Faculty (Research) Mentoring was formed in 2011, in response to: 1) a documented need to assist junior faculty to be more competitive in the grant market and 2) the goal of retaining the best research oriented faculty at Duke.
The Role of Peptide Receptor Radiotherapy (PRRT) in Neuroendocrine Tumors
For the past two decades, development of radiolabeled SSAs has allowed for delivery of radionuclides to somatostatin-receptor (SSTR) expressing tumors. The NETTER-1 trial, an international, randomized phase III study, demonstrated the efficacy of PRRT in advanced Midgut NETs. This talk will review the risks and benefits of treatment with radiolabeled SSAs, and discuss the role of PRRT within the context of other systemic NET treatments.
3D printing is a disruptive technology that has transformed care at The Mayo Clinic over the last 11 years. Additive manufacturing/3D printing started in industrial manufacturing and has quickly spread to medical applications. While not a new technology, it is being applied in new ways. This talk will focus on surgical and educational applications of 3D printing models as well as the regulatory environment and current challenges of in hospital medical 3D printing.
Morbidity & Mortality
Department of Radiology Morbidity & Mortality, moderated by Don Frush, M.D., FACR